Cerity Partners’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-44,700
Closed -$102K 1280
2022
Q2
$102K Buy
44,700
+29,710
+198% +$111K ﹤0.01% 1124
2022
Q1
$101K Sell
14,990
-1,297
-8% -$11.1K ﹤0.01% 896
2021
Q4
$147K Buy
16,287
+1,446
+10% +$13.4K ﹤0.01% 957
2021
Q3
$150K Buy
14,841
+61
+0.4% +$669 ﹤0.01% 661
2021
Q2
$190K Hold
14,780
﹤0.01% 681
2021
Q1
$209K Sell
14,780
-2,500
-14% -$34.4K 0.01% 651
2020
Q4
$184K Sell
17,280
-3,000
-15% -$27.3K 0.01% 610
2020
Q3
$155K Hold
20,280
0.01% 475
2020
Q2
$123K Buy
+20,280
New +$100K 0.01% 437

Other funds holding DBD

Cerity Partners's DBD Position: Q3 2022 in Review

Cerity Partners sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2022, closing a stake of 44,700 shares — an estimated $102K sold.

Cerity Partners first reported a position in DBD in Q2 2020 and held it in 9 quarters. The position peaked at $209K in Q1 2021. 165 funds tracked by Wall St. Rank hold DBD as of Q3 2022.

  • Cerity Partners reported no remaining Diebold Nixdorf Incorporated position as of Q3 2022 after selling out during the quarter.
  • Cerity Partners sold 44,700 Diebold Nixdorf Incorporated shares in Q3 2022, an estimated $102K.
  • Cerity Partners first reported a position in Diebold Nixdorf Incorporated in Q2 2020 and held it in 9 quarters.
  • Cerity Partners's Diebold Nixdorf Incorporated position peaked at $209K in Q1 2021.
  • 165 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2022.

Based on Cerity Partners's 13F filing for Q3 2022, filed 14 Nov 2022.